Trial Site Detail

 

Drug:	Ripretinib
Trial:	Ripretinib Used for Resectable Metastatic GIST After Failure of Imatinib Therapy
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Recruiting

 

Renji Hospital Shanghai Jiao Tong University School of Medicine       Shanghai , Shanghai 200127 China

 

Principal Investigator:	Hui Cao, Professor
Contact:	13918141425 caohuishcn@hotmail.com
Activation Status of this Site:	Active
Notes about this Site:
Renji Hospital Shanghai Jiao Tong University School of Medicine Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.